SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Update research from QuotedData

20 Jan 2023 16:29

RNS Number : 4534N
RTW Venture Fund Limited
20 January 2023
 

 

 

QuotedData's Investment Trust Weekly News Round-up Show - Stephanie Sirota from RTW Venture Fund

On the 20th January, James Carthew talked through the Weekly News and interviewed Stephanie Sirota from RTW Venture Fund - Watch here.

About our Weekly Show:

The best way to enjoy the show is to join our weekly webinar live, at 11 am every Friday, where we discuss the key stories and events in the investment companies' sector over the last week. We also invite a guest every week and give you the opportunity to get answers to your questions.

Click here to view our previous recordings: https://quoteddata.com/events/?past=true

Click here to view our upcoming events: https://quoteddata.com/events/

This information is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. QuotedData is a trading name of Marten & Co Limited, which is authorised and regulated by the Financial Conduct Authority. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.

QUOTEDDATA50 Gresham Street | London | EC2V 7AY | UKTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAURANROVUAUAR
Date   Source Headline
12th Jun 20267:00 amRNSMonthly Valuation Update and Factsheet
11th Jun 20264:45 pmRNSResult of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 20267:00 amRNSNotice of AGM
14th May 20267:00 amRNSMonthly Valuation Update and Factsheet
12th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSAdditional investment in Windward Bio
6th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20263:00 pmRNSAnnual Financial Report
24th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSKailera completes $625 million IPO
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSReplacement RNS: Monthly Valuation Update
15th Apr 20267:01 amRNSObsidian Therapeutics reverse merger with Galera
15th Apr 20267:00 amRNSMonthly Valuation Update and Factsheet
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:01 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSApellis and Centessa to be acquired
31st Mar 20267:01 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSAmani closes $25 million Series A financing
30th Mar 20267:01 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Financial Report
27th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.